## Abstract Mammalian target of rapamycin (mTOR) inhibitors modulate signaling pathways involved in cell cycle progression, and recent phase II trials demonstrate activity in patients with endometrial cancer. Our objective was to examine the effects of combination therapy with rapamycin and paclita
Synergistic effect of rapamycin and cisplatin in endometrial cancer cells
β Scribed by Victoria L. Bae-Jump; Chunxiao Zhou; John F. Boggess; Paola A. Gehrig
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 346 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The synergistic antitumor activity of mitomycin C (MMC) and cisplatin (DDP) against the gastric cancer cell lines MKN-28 and MKN-45 was assessed in vitro using the MTT assay. The synergism of the two agents was evaluated in terms of the interaction index (1.1.). The sequence of MMC followed by DDP s
From clinical experience it is known that medroxyprogesterone acetate (MPA) can increase 'the radiosensitivity of adenocarcinomas of the corpus uteri. This study investigates this phenomenon in vitro. Primary explants of highly differentiated adenocarcinomas were irradiated with or without pretreatm
The effect of rapamycin (RAPA) and cyclosporine A (CsA) monotherapy and combination therapy was examined in prevention of kidney allograft rejection in the mouse. Both drugs were administered orally for up to 14 days in BALB/c (H-2 d ) to C57BL/6 (H-2 b ) mice strong combination. Six groups were tre
Malignant mesothelioma (MM) still remains a therapeutic and diagnostic problem to which new therapeutic perspectives are being continuously tried and tested. Three different primary cultures (MMGe-1, MES MM 98, and MES 1) and one immortalized cell line (MSTO 211 H) of human MM were studied in order
## Abstract Several proangiogenic/proinflammatory factors involved in endometrial cancer are regulated by leptin, but the signaling mechanisms responsible for these leptinβinduced actions are largely unknown. Here, we report that in benign (primary and HES) and cancerousβendometrial epithelial cell